Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38757

DIAPH3 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The DIAPH3 Knockout MES-OV Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of MES-OV human ovarian clear cell carcinoma cells with targeted disruption of the DIAPH3 gene. This model enables loss-of-function analysis of the formin protein DIAPH3, which nucleates actin polymerization downstream of RhoA and Rac1 and stabilizes microtubules via interactions with APC. Ideal for investigating cell migration, invasion, and actin cytoskeletal dynamics in ovarian cancer, this knockout model supports Transwell assays, phalloidin staining, and western blotting to dissect Rho GTPase signaling and integrin-dependent adhesion pathways.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    DIAPH3

    Gene Identifier

    NCBI Gene ID 81624

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DIAPH3 Knockout MES-OV Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population of the DIAPH3 gene in the human ovarian clear cell carcinoma cell line MES-OV. This polyclonal knockout model enables loss-of-function studies of the formin protein DIAPH3, a key regulator of actin dynamics and cell migration. By using a polyclonal population of gene-disrupted cells, researchers can analyze the collective effects of DIAPH3 ablation without clonal isolation, offering a robust system for investigating metastatic behavior in ovarian cancer.

The MES-OV cell line was derived from a human ovarian clear cell carcinoma and serves as a well-characterized model for ovarian cancer research. Ovarian clear cell carcinoma is a distinct histotype associated with chemoresistance and poor prognosis, making it essential to study the molecular drivers of its invasive phenotype. MES-OV cells retain properties of the tumor microenvironment, including responsiveness to Rho GTPase signaling and extracellular matrix cues, providing a relevant cellular context for examining cytoskeletal remodeling and cell adhesion.

DIAPH3 is a member of the formin family and functions downstream of RhoA and Rac1 GTPases, which are activated by PI3K/Akt and integrin signaling. Upon activation, DIAPH3 nucleates actin polymerization through its interactions with profilin and globular actin, leading to the formation of linear F-actin filaments. Additionally, DIAPH3 stabilizes microtubules by associating with microtubule-associated proteins and the adenomatous polyposis coli (APC) protein, thereby coordinating actin and microtubule cytoskeletal networks. This dual functionality positions DIAPH3 at a crossroad of cytoskeletal dynamics, with ROCK and mDia acting as representative components of the same signaling pathway. Downstream, DIAPH3-dependent actin assembly contributes to the formation of focal adhesions and invadopodia, structures essential for cell migration and invasion.

In MES-OV ovarian cancer cells, DIAPH3 plays a critical role in promoting cell motility and invasion, processes that underpin peritoneal dissemination and metastasis. Knockout of DIAPH3 using this polyclonal cell population impairs actin filament nucleation and microtubule stabilization, resulting in diminished cell migration and adhesion. This model allows for the dissection of DIAPH3??s specific contributions to the invasive phenotype of ovarian clear cell carcinoma, independent of other formin family members. Moreover, the polyclonal nature ensures that the observed phenotypes are not artifacts of clonal selection, increasing the translational relevance of findings to heterogeneous tumor cell populations.

This polyclonal DIAPH3 knockout cell product is ideally suited for a range of functional assays, including Transwell migration and invasion assays, phalloidin staining to visualize F-actin organization, western blotting to assess downstream signaling changes, and RT-qPCR to quantify gene expression alterations. Researchers can employ this model to investigate the role of DIAPH3 in Rho GTPase-mediated cytoskeletal reorganization, evaluate integrin-dependent cell adhesion dynamics, or screen for compounds that target metastatic pathways in ovarian cancer. For further information or to discuss custom applications, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)